Topical testosterone treatment for chronic allograft failure in liver transplant recipients with recurrent hepatitis C virus
β Scribed by G.W. Neff; C.B. O'Brien; N.J. Shire; A. DeManno; S. Kahn; E. Rideman; K. Safdar; J. Madariaga; S.R. Rudich
- Book ID
- 116930516
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 119 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Adherence to antiviral therapy is essential to achieve sustained virological responses in patients treated for hepatitis C. An important limitation to use of appropriate doses of ribavirin is development of anemia. The aim of this study is to identify risk factors associated with anemia in liver tra
Hepatitis G virus (HGV) is a newly described RNA virus that is parenterally transmitted and has been found frequently in patients with chronic hepatitis C infection. To determine the impact of hepatitis G virus co-infection on morbidity and mortality following liver transplantation, we measured HGV